PHK
XERS icon

Point72 Hong Kong’s Xeris Biopharma Holdings XERS Stock Holding History

Point72 Hong Kong’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,558
Closed -$2K – 1716
2022
Q3 		$2K Buy
+1,558
New +$2.58K ﹤0.01% 1858
2021
Q3 		– Sell
-862
Closed -$4K – 2502
2021
Q2 		$4K Buy
862
+593
+220% +$2.26K ﹤0.01% 1814
2021
Q1 		$1K Sell
269
-1,192
-82% -$6.43K ﹤0.01% 1733
2020
Q4 		$7K Buy
+1,461
New +$7.31K ﹤0.01% 1571
2018
Q3 		– Sell
-4,670
Closed -$89K – 1211
2018
Q2 		$89K Buy
+4,670
New +$90.8K 0.03% 327

Other funds holding XERS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Point72 Hong Kong's XERS Position: Q4 2022 in Review

Point72 Hong Kong sold out of Xeris Biopharma Holdings (XERS) in Q4 2022, closing a stake of 1,558 shares — an estimated $2K sold.

Point72 Hong Kong first reported a position in XERS in Q2 2018 and held it in 5 quarters. The position peaked at $89K in Q2 2018. 97 funds tracked by Wall St. Rank hold XERS as of Q4 2022.

  • Point72 Hong Kong reported no remaining Xeris Biopharma Holdings position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,558 Xeris Biopharma Holdings shares in Q4 2022, an estimated $2K.
  • Point72 Hong Kong first reported a position in Xeris Biopharma Holdings in Q2 2018 and held it in 5 quarters.
  • Point72 Hong Kong's Xeris Biopharma Holdings position peaked at $89K in Q2 2018.
  • 97 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.